In this line, results from a multinational cohort of patients with advanced cancer (age 54–70 years) reported that elevated levels of C-reactive protein (CRP) were significantly associated with appetite loss, cognitive and physical dysfunction, pain and fatigue [10]. The gene discussed is CRP; the disease is cancer.